pSivida Corp. Achieves Significant Milestones Throughout FY 2017; Reports Fourth Quarter and Fiscal 2017 Results
Sep 11, 2017
|
pSivida to Present at Rodman & Renshaw Annual Global Investment Conference
Sep 11, 2017
|
pSivida Corp. to Report Fourth Quarter and Fiscal Year 2017 Financial Results on Monday, September 11th
Sep 05, 2017
|
pSivida to Present at Canaccord Genuity Growth Conference on August 10, 2017
Aug 01, 2017
|
Leading Retinal Specialists to Highlight pSivida's Durasert for Treatment of Posterior Segment Uveitis at Prestigious Ophthalmology Conferences
Jul 18, 2017
|
pSivida Out-licenses EMEA Rights for Durasert™ Three-year Treatment for Posterior Segment Uveitis While Retaining U.S. Commercial Rights; Amended Global Collaboration Agreement with Alimera for ILUVIEN® Improves pSivida's Revenue Generation
Jul 10, 2017
|
pSivida Enhances Board of Directors with Election of Veteran Healthcare Executive Kristine Peterson
Jun 28, 2017
|
pSivida Submits Marketing Authorization Application (MAA) for Approval of Durasert™ Three-year Treatment for Posterior Segment Uveitis in the European Union
Jun 22, 2017
|
pSivida's Durasert™ Three-year Treatment for Posterior Segment Uveitis Successfully Achieves Primary Efficacy Endpoint in Second Phase 3 Study
Jun 13, 2017
|
Durasert™ Three-year Treatment for Posterior Segment Uveitis Significantly Reduces Recurrences Through 12 Months
May 08, 2017
|
pSivida Corp. Reports Fiscal 2017 Third Quarter Results; Key Milestones on Track
May 04, 2017
|
pSivida Corp. to Report Third Quarter Fiscal Year 2017 Financial Results on Thursday, May 4th
Apr 19, 2017
|
Abstract on pSivida's Treatment of Posterior Segment Uveitis Accepted for Presentation at the 2017 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Mar 15, 2017
|
pSivida to Present at the 2017 BIO CEO & Investor Conference
Feb 10, 2017
|
pSivida Corp. Reports Fiscal 2017 Second Quarter and First Half Results
Feb 07, 2017
|
pSivida Corp. Announces Second Quarter Fiscal Year 2017 Financial Results Release Date and Conference Call Information
Jan 25, 2017
|
Seasoned Ophthalmology Executive Deb Jorn Joins pSivida to Focus on Corporate and Commercial Development
Nov 07, 2016
|
pSivida Corp. Reports Fiscal 2017 First Quarter Results and Provides Update on Corporate Objectives & Milestone Timeline
Nov 07, 2016
|
pSivida Corp. Announces First Quarter Fiscal Year 2017 Financial Results Release Date and Conference Call Information
Oct 31, 2016
|
Phase 3 trial of Medidur™ in Posterior Segment Uveitis Meets Enrollment Target
Oct 04, 2016
|